Dyne Therapeutics Inc (NASDAQ:DYN)

14.78
Delayed Data
As of 3:38pm ET
 +0.14 / +0.96%
Today’s Change
4.30
Today|||52-Week Range
15.63
+27.52%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Atlas Venture Life Science Advisors Llc
Buy12/12/2022934,581$10.70$10.0M+25.32%
Atlas Venture Life Science Advisors Llc
Director
Buy12/12/2022934,581$10.70$10.0M+25.32%
Brumm Joshua T
Director
Sale10/10/2022195,800$12.46$2.4M+15.60%
Mcneill Jonathan /dyne/
Corporate Officer
Sale1/09/202330,150$11.57$348.8K+27.51%
Brumm Joshua T
Director
Buy10/10/2022195,800$1.03$201.7K+15.60%
Brumm Joshua T
Director
Sale10/07/202214,200$13.37$189.9K+14.78%
Brumm Joshua T
Director
Sale9/20/202211,836$13.70$162.2K+5.95%
Mcneill Jonathan /dyne/
Corporate Officer
Sale1/18/202310,000$14.03$140.3K+5.57%
Brumm Joshua T
Director
Sale7/06/202210,963$8.24$90.3K+77.40%
Brumm Joshua T
Director
Sale9/15/20223,480$14.05$48.9K+4.29%
Page of 5